Literature DB >> 1372659

Variability and circadian changes in home uroflowmetry in patients with benign prostatic hyperplasia compared to normal controls.

J Golomb1, A Lindner, Y Siegel, D Korczak.   

Abstract

We evaluated the variability and circadian changes in consecutive measurements of home uroflowmetry in 32 patients with symptomatic benign prostatic hyperplasia (BPH) and 16 healthy men. In the BPH group 476 uroflow measurements were recorded during 24 to 72 hours (mean 14.9 measurements per patient), and the controls produced 100 flow recordings (mean 6.25 measurements per participant). Great variability between consecutive peak flow rates was observed in the BPH group, ranging from at least 1 standard deviation in 28 of 32 patients (87.5%) to at least 2 standard deviations in 15 of 32 (47%). In 21 of 32 patients (65.6%) the highest recorded peak flow rate was greater than, while the lowest peak flow rate was less than the -2 standard deviations plot in voiding nomograms. In the control group variability between consecutive voiding episodes also was marked, namely at least 1 standard deviation in 8 of 16 men (50.0%) and at least 2 standard deviations in 2 of 16 (12.5%). However, in none of the control men was any peak flow rate measurement less than the -2 standard deviations line. Circadian changes in diurnal and nocturnal measurements of voided volume, interval to maximal flow, flow time, peak flow rate and adjusted peak flow rate were recorded in the BPH group, providing a urodynamic support to a well known clinical observation.

Entities:  

Mesh:

Year:  1992        PMID: 1372659     DOI: 10.1016/s0022-5347(17)37462-1

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  14 in total

1.  Long-term efficacy and safety of a combination of sabal and urtica extract for lower urinary tract symptoms--a placebo-controlled, double-blind, multicenter trial.

Authors:  N Lopatkin; A Sivkov; C Walther; S Schläfke; A Medvedev; J Avdeichuk; G Golubev; K Melnik; N Elenberger; U Engelmann
Journal:  World J Urol       Date:  2005-06-01       Impact factor: 4.226

Review 2.  Uroflowmetry in elderly men.

Authors:  K M Jensen
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

3.  Comparison of voiding disturbances in patients with LUTS and BPH at home and by episodic checks at an outpatient clinic.

Authors:  W Satoh; T Nakada
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

4.  Clinical validation of an audio-based uroflowmetry application in adult males.

Authors:  Mark T Dawidek; Rohit Singla; Lucie Spooner; Louisa Ho; Christopher Nguan
Journal:  Can Urol Assoc J       Date:  2022-03       Impact factor: 1.862

Review 5.  Pelvic ultrasound evaluation for benign prostatic hyperplasia: prediction of obstruction.

Authors:  Daniel B Rukstalis
Journal:  Curr Urol Rep       Date:  2014-05       Impact factor: 3.092

6.  Male Voiding Behavior: Insight from 19,824 At-Home Uroflow Profiles.

Authors:  Stephen J Summers; Joseph M Armstrong; Steven A Kaplan; Alex E Te; Alvin Le; Scott M Heiner; Angela P Presson; Guo Wei; James M Hotaling
Journal:  J Urol       Date:  2020-12-01       Impact factor: 7.450

7.  Visual assessment of uroflowmetry curves: description and interpretation by urodynamists.

Authors:  Mauro Gacci; Giulio Del Popolo; Walter Artibani; Andrea Tubaro; Domenico Palli; Gianni Vittori; Alberto Lapini; Sergio Serni; Marco Carini
Journal:  World J Urol       Date:  2007-04-14       Impact factor: 3.661

Review 8.  Current concepts and controversies in urodynamics.

Authors:  C E Kelly; R J Krane
Journal:  Curr Urol Rep       Date:  2000-10       Impact factor: 2.862

9.  Clinical evaluation of a simple uroflowmeter for categorization of maximum urinary flow rate.

Authors:  Simon Pridgeon; Christopher Harding; Douglas Newton; Robert Pickard
Journal:  Indian J Urol       Date:  2007-04

10.  The shape of the urine stream--from biophysics to diagnostics.

Authors:  Andrew P S Wheeler; Samir Morad; Noor Buchholz; Martin M Knight
Journal:  PLoS One       Date:  2012-10-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.